AdaptHealth AHCO Income Statement (2018-2026)

NASDAQ AHCO
$5.70 -0.49 (-7.92%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

AdaptHealth Quarterly Income Statement

Periods 34 quarters
Latest Jun 2026

AdaptHealth reported revenue of $740.31M and net income of -$145.32M for the quarter ended Jun 2026, up 12.7% year over year. This income statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
653.29M702.11M706.20M727.61M756.50M780.28M744.63M793.29M804.03M858.23M792.50M805.98M805.86M856.64M777.88M657.10M820.31M846.29M819.80M740.31M
Cost of RevenueCost of Rev
529.89M591.62M597.12M610.01M646.71M536.63M655.40M673.40M693.49M553.83M635.03M636.62M643.79M664.43M657.44M521.31M658.37M674.13M708.30M636.10M
Gross Profit
123.41M110.49M109.08M117.60M109.78M243.65M89.23M119.89M110.54M304.40M157.47M169.35M162.06M192.21M120.44M135.79M161.94M172.16M111.50M104.21M
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
59.70M65.00M67.10M69.40M82.40M92.30M83.80M89.30M90.30M86.80M87.30M85.60M85.20M85.00M89.20M84.80M92.60M92.50M101.60M112.80M
Selling, General & AdministrativeSG&A
33.01M34.92M41.44M42.55M40.68M200.14M47.52M50.08M45.20M191.80M89.04M99.36M87.31M83.52M86.85M95.26M90.11M107.89M95.91M96.09M
Other Operating ExpensesOther Opex
484.88M543.70M546.11M556.49M580.47M461.11M587.13M599.65M1,129.57M797.44M565.62M578.66M32.23M0.38M616.80M6.27M
Operating ExpensesOpex
577.58M643.62M654.65M668.44M703.55M753.55M718.45M739.02M1,265.07M1,076.04M741.97M753.93M742.37M758.98M754.71M623.63M758.58M919.95M814.31M884.38M
Operating IncomeOp. Inc
75.71M69.08M51.55M59.18M52.95M26.73M26.18M54.26M-461.04M-217.80M50.53M52.05M63.49M97.67M23.17M65.69M61.73M-73.28M5.49M-137.80M
EBIT
75.71M69.08M51.55M59.18M52.95M26.73M26.18M54.26M-461.04M-217.80M50.53M52.05M63.49M97.67M23.17M65.69M61.73M-73.28M5.49M-137.80M
Non-operating items
Non Operating Interest Expenses
24.25M25.61M24.78M25.61M28.52M30.51M31.95M32.55M32.31M33.49M32.47M33.04M31.43M
Interest & Investment IncomeInt & Inv Inc
-32.47M-33.04M-31.43M-29.73M-28.40M-27.53M-25.38M-24.44M-25.59M-26.21M
Other Non Operating IncomeOther Non Op Inc.
-8.24M-5.66M-1.26M-0.26M6.93M-1.18M-2.08M-3.32M-22.99M-5.11M1.76M-2.27M0.55M-0.27M-1.32M
Net income details
EBT
70.41M33.49M47.83M24.10M22.81M3.16M14.96M20.44M-487.50M-271.69M5.50M27.78M32.03M70.71M-5.23M38.16M36.35M-97.99M-20.11M-165.33M
Tax ProvisionsTaxes
12.15M10.01M5.60M8.90M5.60M4.76M-1.71M5.40M-34.60M-18.10M6.61M7.25M8.10M19.31M0.90M32.80M10.60M3.56M-5.23M-21.23M
Profit After TaxPAT
58.27M23.47M42.23M15.25M17.23M-1.57M16.68M15.04M-454.08M-254.50M-1.11M20.53M23.95M51.40M-6.08M15.83M25.75M-106.29M-14.87M-145.32M
Income from Non-Controlling InterestsInc. Minority
0.17M0.53M0.48M1.22M1.10M1.02M0.97M1.06M1.16M0.93M1.02M1.10M1.10M1.14M1.13M1.15M1.24M1.23M1.17M1.21M
Income from Continuing OperationsIncome (Continuing)
58.27M23.49M42.23M15.20M17.21M-1.60M16.68M15.04M-452.90M-253.58M-1.11M20.53M23.93M51.40M-6.13M5.36M25.75M-101.55M-14.87M-144.11M
Income from Discontinued OperationsIncome (Discontinued)
10.45M11.39M
Consolidated Net IncomeConsol Net Inc.
58.27M23.49M42.23M15.20M17.21M-1.60M16.68M15.04M-452.90M-253.58M-1.11M20.53M23.93M51.40M-6.13M15.81M25.75M-101.55M-14.87M-132.72M
Income towards Parent CompanyParent Net Inc
58.27M23.49M42.23M15.20M17.21M-1.60M16.68M15.04M-452.90M-253.58M-1.11M20.53M23.93M51.40M-6.13M15.81M25.75M-101.55M-14.87M-132.72M
Net Income towards Common StockholdersNet Income
53.09M21.14M38.21M12.85M14.76M-1.60M16.68M15.04M-452.90M-253.58M-1.11M20.53M23.93M51.40M-6.13M15.81M25.75M-101.55M-14.87M-132.72M
Additional items
EPS (Basic)
0.400.170.290.100.11-0.010.120.11-3.36-1.89-0.010.150.180.38-0.050.120.19-0.75-0.11-0.98
EPS (Diluted)
0.380.160.280.090.11-0.010.120.11-3.36-1.89-0.010.150.180.38-0.050.120.19-0.75-0.11-0.98
Shares Outstanding
131.68M126.31M134.02M134.33M134.23M134.18M134.53M134.29M134.82M134.16M132.91M133.22M134.30M133.76M134.80M134.99M135.34M135.15M135.78M136.12M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
140.32M133.03M138.48M137.01M137.58M138.99M135.98M136.23M134.98M134.42M132.91M136.03M136.53M135.53M134.80M137.07M137.21M135.15M135.78M136.12M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
132.22M133.84M134.25M134.25M134.72M134.44M134.15M134.52M134.99M132.63M133.19M133.38M134.54M134.60M134.94M135.22M135.42M135.45M136.01M136.31M
EBITDA
135.41M134.08M118.65M128.58M135.35M119.03M109.98M143.56M-370.74M-131.00M137.83M137.65M148.69M182.67M112.37M150.49M154.33M19.22M107.09M-25.00M
Interest ExpensesInt Expense
24.25M25.61M24.78M25.61M28.52M30.51M31.95M32.55M32.31M33.49M32.47M33.04M31.43M
Tax Rate
17.25%29.87%11.71%36.93%24.55%150.66%-11.46%26.42%7.10%6.66%120.16%26.09%25.29%27.31%-17.21%85.95%29.16%-3.63%26.02%12.84%